Brown Rudnick advises N+1 Singer in relation to Realm Therapeutics PLC placing on AIM
PUBLISHED ON: 10/10/2017
Brown Rudnick acted on behalf of the nomad/broker, N+1 Singer, Realm Therapeutics PLC announced on 21 September 2017 to raise £19.3 million on AIM. The Placing comprises of a UK Placing and a US Placing. It is expected that the Placing Shares will be admitted to trading on AIM on or around 10 October.
Realm Therapeutics is a clinical stage biopharmaceutical company developing small molecule therapies with potential application for the treatment of diseases in a number of therapeutic areas, and with an initial focus in dermatology and ophthalmology.
To learn more about this deal please read the following press release: